ArticleScientific reports2026
SMAD2 ubiquitination through PY motif regulates skeletal muscle mass and fibrotic degeneration.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- E3 ligase SMURF2 promotes adipogenesis and improves obesity complications by suppressing TGF-β signaling.Journal of lipid research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Transforming growth factorβ (TGFβ) signaling regulates diverse aspects of vertebrate skeletal muscle tissue including differentiation, homeostasis, regeneration and pathogenic degeneration. Ubiquitination of SMAD2, an intracellular transducer of TGFβ signaling, is a well-studied negative feedback regulation of the signaling pathway in the field of cell biology, but it's relevance in skeletal muscle tissue has been elusive. In this study, to elucidate the in vivo role of SMAD2 ubiquitination, we generated Smad2dPY mutant mice in which a 15 bp sequence encoding the PY motif of SMAD2 protein is deleted from Smad2 gene. By removing this motif, the SMAD2 protein escapes from protein-protein interaction with NEDD4 family E3 ligases and thus is devoid of ubiquitination-dependent negative regulation. Smad2dPY mice showed no obvious abnormality in development, growth or fertility, indicating that SMAD2 ubiquitination through PY motif is dispensable for these processes. The skeletal muscle of Smad2dPY mice demonstrated reduced weight and myofiber size reduction at 12 months old. SMAD2 protein level was increased in the skeletal muscle of Smad2dPY mice while SMAD2 ubiquitination was reduced. Primary myoblasts of Smad2dPY mice displayed higher TGFβ responsiveness and suppressed terminal differentiation, which may explain the reduced muscle mass. The TGFβ responsiveness of the interstitial fibroblast population was also increased. Fibrotic tissue remodeling triggered by cardiotoxin injection was exacerbated in Smad2dPY mice. Altogether, our study identified SMAD2 ubiquitination through PY motif as an important regulatory mechanism operating in skeletal muscle tissue to maintain the TGFβ signaling pathway at the desired level in homeostasis and tissue remodeling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.